Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer

Anticancer Research

Volumn 19, Issue 1 B, 1999, Pages 731-740

  Salh, Baljinder ^a   Marotta, Anthony ^a   Matthewson, Carrie ^a   Ahluwalia, Monica ^a   Flint, Julia ^a   Owen, David ^a   Pelech, Steven ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Breast cancer; Erk1; Erk2; Immunolocalization; Mek

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN BASIC PROTEIN; PHOSPHOTRANSFERASE;

ARTICLE; BREAST CANCER; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL;

ANION EXCHANGE RESINS; ANTIGENS, NUCLEAR; BLOTTING, WESTERN; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MYELIN BASIC PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESINS, SYNTHETIC; SIGNAL TRANSDUCTION;

EID: 0032899640     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hulka B, Stark AT: Breast cancer: Cause and prevention. Lancet 346: 883-887, 1995.
2. Pelech S, Sanghera JS: Mitogen-activated protein kinases, versatile transducers in cell signalling. Trends Biochem Sci 17: 233-238, 1992
3. Moodie SA, Willumsen BM, Weber MJ, Wolfman A: Complexes of Ras-GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260: 1658-1661, 1993.
4. Waskiewicz AW, Cooper JA: Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Current Opinion in Cell Biology 7: 798-805, 1995.
5. Mansour EG, Ravdin PM, Dressler L: Prognostic factors in early breast cancer. Cancer 74: 381-400, 1994.
6. Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989.
7. White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M, Wigler MH: Ras functions can contribute to mammalian cell transformation. Cell 80: 533-541, 1995.
8. Ottenhhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels A, Staal GE: Characterization of protein tyrosine kinases from human breast cancer: Involvement of the c-src oncogene product. Cancer Res 52: 4773-4778, 1992.
9. c-src with two major signalling pathways in human breast cancer. Proc Natl Acad Sci USA 91: 83-87, 1994.
10. Janes PW, Daly RJ, deFazio A and Sutherland RL: Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9: 3601-8, 1994.
11. Migliaccio A, Di Domrnico M, Castoria G, de Falco A, Bontempo P, Nola F, Auricchio E: Tyrosine kinase/p21 ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292-300, 1996.
12. Das R, Vondehaar BK: Activation of Raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Research and Treatment 40: 141-149, 1996.
13. Biscardi JS, Belsches AP, Parsons SJ: Characterization of human epidermal growth factor receptor and c-src interactions in human breast tumor cells. Mol Carcinog 21: 261-272, 1998.
14. Cowley S, Paterson H, Kemp P, Marshall CJ: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852, 1994.
15. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970, 1994.
16. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254, 1976.
17. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227: 680-685, 1970.
18. Atten MJ, Attar BM, Holian O: Decreased MAP kinase activity in human gastric adenocarcinoma. Biochem Biophys Res Commun 212: 1001-116, 1995.
19. Sivaraman VS, Wang HY, Nuovo GJ, Malbon CC: Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 99: 1478-1483, 1997.
20. Takashima K, Griswold-Prenner I, Ingebritsen T, Rosner MR: Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated 'MAP' kinase. Proc Natl Acad Sci USA 88: 2520-2524, 1991.
21. Torres M, Hall FL, O'Neill K: Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein kinases J Immunol 150: 1563-1578, 1993.
22. Blenis J: Signal transduction via the MAP kinases: Proceed at your own risk. Proc Natl Acad Sci USA 90: 5889-5892, 1993.
23. Attar BM, Atten MJ, Holian O: MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity. Anticancer Res 16: 395-400, 1996.
24. Larson PS, de las Morenas A, Cupples LA, Huang K, Rosenberg CL: Genetically abnormal clones in histologically normal breast tissue. Am J Pathol 152: 1591-1598, 1998.
25. Loda M, Capodieci P, Mishra R, Yao H, Corless C, Grigioni W, Wang Y, Magi-Galluzi C, Stork PJS: Expression of Mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol 149: 1553-1564, 1996.
26. Chen Q, Lin TH, Der CD, Juliano RL: Integrin-mediated activation of MAP or MEK kinase is independent of Ras. J Biol Chem 271: 18122-18127, 1996.
27. Varner JA, Cheresh DA: Integrins and cancer. Current Opinion in Cell Biology 8: 724-730, 1996.
28. Amundadottir LT, Leder P: Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 16: 737-746, 1998.
29. Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, Yoshida O: Constitutive activation of Mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 55: 4182-4187, 1995.
30. Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A, Ueki T, Hirano T, Yamamoto H, Fujimoto J, Okamoto E, Hayashi N, Hori M: Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 27: 951-958, 1998.
31. Clark JW, Santos-Moore A, Stevenson LE, Frackleton AR: Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the Ras signalling pathway. Int J Cancer 65: 186-191, 1996.